Avanos Medical Clears Regulatory Hurdles for $3.6 Billion AIP Takeover
Event summary
- Avanos Medical received all required regulatory approvals for its $3.6 billion acquisition by American Industrial Partners (AIP).
- The deal is expected to close by July 27, 2026, pending stockholder approval at a special meeting on July 22.
- AIP manages approximately $17.8 billion in assets and has completed over 145 platform acquisitions.
The big picture
The acquisition marks a shift from public to private ownership for Avanos, aligning with broader trends of PE firms targeting mid-cap medical device companies. With $17.8 billion in AUM and a track record of transformative investments, AIP aims to leverage Avanos' portfolio to drive operational efficiencies and expand market reach. The deal underscores the growing appetite for engineered products businesses among industrials investors.
What we're watching
- Governance Dynamics
- How AIP's operational focus will reshape Avanos' strategic direction and innovation pipeline.
- Execution Risk
- The pace at which AIP integrates Avanos and delivers on promised growth initiatives.
- Market Positioning
- Whether Avanos can maintain its leading market positions under private equity ownership.
Related topics